Income disparities and accessibility to Semaglutide: implications for diabetes management and policy reform

Article (Faculty180)

cited authors

  • Vaidya, Varun; Estep, Sophia; Gupte, Renuka

description

  • <p>Semaglutide, a glucagon-like peptide-1(GLP-1) receptor agonist, is an effective treatment for type 2 diabetes and weight loss. However, its high cost poses a significant barrier to access for those who need it more. This study investigated if socioeconomic factors affected the use of semaglutide among patients with type 2 diabetes and if there are income disparities in its utilization.</p>

authors

publication date

  • 2026

published in

volume

  • 38